Description
Human Renal Adenocarcinoma Cells (ACHN) were derived from a Renal Adenocarcinoma patient. RFP-Human Renal Adenocarcinoma Cells (ACHN) are selected from the Human Renal Adenocarcinoma Cells (ACHN) after transfected with RFP expressing lentiviruses resistant to puromycin. Cells are supplied in frozen vials with more than 5x10^5 cells/vial. Universal Full Growth Medium (TM001) is recommended to culture the cells.
Cells are prepared and manufactured in an ISO 9001:2015 certified environment and ISO 5 cleanroom.
Product Highlights:
You'll also need
What this product needs to grow and work as described.
- Universal Coating SolutionAC002 · 20 ml$272.40
- Universal Detachment SolutionAD002 · 100 ml$108.00
- Universal Full Growth MediumTM001 · 500 ml$315.60
- Universal Neutralization BufferNB001 · 100 ml$93.60
Related products
- GFP Expressing Human Brain Glioblastoma Cells (LN-18)
- GFP Expressing Human Brain Glioblastoma Cells (LN-229)
- GFP Expressing Human Gastric Carcinoma N87 Cells
- GFP Expressing Human Glioblastoma Cells
- GFP Expressing Human Prostate Carcinoma Cells (DU 145)
- GFP Expressing Human Renal Adenocarcinoma Cells (ACHN)
- RFP Expressing Human Brain Glioblastoma Cells (LN-18)
- RFP Expressing Human Brain Glioblastoma Cells (LN-229)
- RFP Expressing Human Gastric Carcinoma N87 Cells
- RFP Expressing Human Glioblastoma Cells
- RFP Expressing Human Prostate Carcinoma Cells (DU 145)
For research use only. Not for diagnostic or clinical use.